Galectin‐9 was highly expressed in MDSCs, and Gal‐9 was also elevated in bone marrow supernatants, serum and culture supernatants of MDSCs from MDS patients compared to those from normal controls. This evidence concerns the gene LGALS9 and myelodysplastic syndrome.